Literature DB >> 26439479

Antiviral effects of Yinhuapinggan granule against influenza virus infection in the ICR mice model.

Xue-qian Peng1, Hui-fen Zhou1, Yu-yan Zhang1, Jie-hong Yang1, Hai-tong Wan2, Yu He3.   

Abstract

Yinhuapinggan granule (YHPG), a Chinese medicine granule based on Ma-Huang-Tang (Ephedra Decoction) and the clinical experience of Professor Wan Haitong, is used in traditional Chinese medicine (TCM) for the treatment of colds, influenza, fever, inflammation and cough. This study investigated the antiviral effects of YHPG on the production of inflammatory cytokines in influenza virus (IFV)-infected mice and evaluated the effect of YHPG on the expression of NF-κB p65 and the level of key signaling molecules in the TLR4 signaling pathway. ICR mice were orally administrated YHPG at doses of 7.5, 15 and 30 g kg(-1) day(-1) for 2 or 6 days after IFV infection. On days 3 and 7 after infection, YHPG (15 g/kg and 30 g/kg) significantly increased levels of interleukin (IL)-2 and interferon gamma and decreased levels of IL-4, IL-5 and tumor necrosis factor (TNF) in serum compared with the IFV control group. Furthermore, the expression of TLR4, MyD88, TRAF6 and NF-κB p65 at the mRNA and protein level was significantly lower in the YHPG (15 and 30 g/kg) treatment groups than in the IFV control group. These results suggest that YHPG has antiviral effects in IFV-infected mice, which is associated with the inhibition of the TLR4-MyD88-TRAF6 signaling pathway and the expression of NF-κB p65.

Entities:  

Keywords:  Antiviral effects; MyD88; NF-κB p65; TLR4; TRAF6; Yinhuapinggan granule

Mesh:

Substances:

Year:  2015        PMID: 26439479     DOI: 10.1007/s11418-015-0939-z

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   3.192


  46 in total

1.  Innate immune stimuli modulate bone marrow-derived dendritic cell production in vitro by toll-like receptor-dependent and -independent mechanisms.

Authors:  Joan E Downes; Stuart Marshall-Clarke
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

2.  Influenza: fatal immunity and the 1918 virus.

Authors:  Yueh-Ming Loo; Michael Gale
Journal:  Nature       Date:  2007-01-18       Impact factor: 49.962

3.  Lactobacillus fermentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response.

Authors:  Jung-Min Yeo; Hyun-Jeong Lee; Jae-Won Kim; Joong-Bok Lee; Seung-Yong Park; In-Soo Choi; Chang-Seon Song
Journal:  Int Immunopharmacol       Date:  2013-11-06       Impact factor: 4.932

4.  IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner.

Authors:  Ido D Weiss; Ori Wald; Hanna Wald; Katia Beider; Michal Abraham; Eithan Galun; Arnon Nagler; Amnon Peled
Journal:  J Interferon Cytokine Res       Date:  2010-06       Impact factor: 2.607

5.  Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.

Authors:  Chung-Fan Hsieh; Cheng-Wei Lo; Chih-Hao Liu; Shiming Lin; Hung-Rong Yen; Tzou-Yien Lin; Jim-Tong Horng
Journal:  J Ethnopharmacol       Date:  2012-06-16       Impact factor: 4.360

6.  [Syndrome differentiation and treatment of Taiyang disease in Shanghan Lun].

Authors:  Xue Yang; Wen-Bo Peng; Xiao-Qiang Yue
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-02

7.  Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.

Authors:  Lan Li; Chen-Huan Yu; Hua-Zhong Ying; Jing-Mao Yu
Journal:  J Ethnopharmacol       Date:  2013-03-15       Impact factor: 4.360

8.  Identification of traditional medicinal plant extracts with novel anti-influenza activity.

Authors:  Dhivya Rajasekaran; Enzo A Palombo; Tiong Chia Yeo; Diana Lim Siok Ley; Chu Lee Tu; Francois Malherbe; Lara Grollo
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

Review 9.  Antiviral agents active against influenza A viruses.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  7 in total

1.  Antiviral effects and mechanisms of Yinhuapinggan granule against H1N1 influenza virus infection in RAW264.7 cells.

Authors:  Hai-Xia Du; Hui-Fen Zhou; Hao-Fang Wan; Jie-Hong Yang; Yi-Yu Lu; Yu He; Hai-Tong Wan
Journal:  Inflammopharmacology       Date:  2018-03-03       Impact factor: 4.473

2.  Anti-Influenza Effect and Mechanisms of Lentinan in an ICR Mouse Model.

Authors:  Huan Cui; Cheng Zhang; Chunmao Zhang; Zhuming Cai; Ligong Chen; Zhaoliang Chen; Kui Zhao; Sina Qiao; Yingchun Wang; Lijia Meng; Shishan Dong; Juxiang Liu; Zhendong Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-05-20       Impact factor: 6.073

3.  Sheng Jiang San, a traditional multi-herb formulation, exerts anti-influenza effects in vitro and in vivo via neuraminidase inhibition and immune regulation.

Authors:  Tianbo Zhang; Mengjie Xiao; Chun-Kwok Wong; Ka-Pun Chris Mok; Xin Zhao; Huihui Ti; Pang-Chui Shaw
Journal:  BMC Complement Altern Med       Date:  2018-05-08       Impact factor: 3.659

4.  Chaiqin Qingning Capsule Inhibits Influenza Virus Infection and Inflammation In Vitro and In Vivo.

Authors:  Jin Zhao; Yanbing Hao; Xuanzi Xia; Runfeng Li; Xiaodong Huang; Zifeng Yang; Xinhua Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-11       Impact factor: 2.629

5.  Screening of Antiviral Components of Yinhuapinggan Granule and Protective Effects of Yinhuapinggan Granule on MDCK Cells with Influenza A/H1N1 Virus.

Authors:  Tianhang Chen; Haixia Du; Huifen Zhou; Jiehong Yang; Jiaqi Zhu; Xin Tong; Yuting Yang; Jiayang Wan; Yichen Fan; Yiyu Lu; Yu He; Haitong Wan
Journal:  Biomed Res Int       Date:  2022-02-15       Impact factor: 3.411

6.  Clinical Efficacy Protocol of Yinhuapinggan Granules: A Randomized, Double-Blind, Parallel, and Controlled Clinical Trial Program for the Intervention of Community-Acquired Drug-Resistant Bacterial Pneumonia as a Complementary Therapy.

Authors:  Jiaoli Wang; Haoran Hu; Haixia Du; Man Luo; Yilan Cao; Jiaping Xu; Tianhang Chen; Yilei Guo; Qixiang Li; Wen Chen; Yifei Zhang; Jin Han; Haitong Wan
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

7.  Preliminary study of Yinhuapinggan granule against H1N1 influenza virus infection in mice through inhibition of apoptosis.

Authors:  Hai-Xia Du; Hui-Fen Zhou; Jie-Hong Yang; Yi-Yu Lu; Yu He; Hai-Tong Wan
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.